Well, the ACC/AHA recommends that chest pain patients, at a minimum, receive an H&P followed by an EKG. After this, risk stratification should be determined as:
The low risk patients will need serial EKGs and Cardiac Biomarkers. If negative, these patients can be discharged home as outpatients and have provocative testing done within 72 hours. Several questions arise from this
There are three recent studies looking at these very questions using an Accelerated Diagnostic Protocol (ADP).
Some issues with these studies: